IL6 and neuroblastoma: Moreover, Ara et al. demonstrated that IL-6 from monocytes activated STAT3 in neuroblastoma cells, causing drug resistance against etoposide and melphalan in vitro, which was counteracted by STAT3 inhibition or knockdown [178].